Haematologica Reports 2005; 1(issue 11): 7-10[prev][index][next]

Retrospective study of thalidomide plus dexamethasone versus conventional chemotherapy in the relapsed multiple myeloma patient and the study of melphalan and prednisone versus
melphalan, prednisone, and thalidomide
Mario Boccadoro
Ospedale San Giovanni Battista (Molinette), via Genova 3, 10126 Torino, Italy
Phone: +39.011.6635814
E-mail: mario.boccadoro@unito.it

Thalidomide shows promise in the treatment of multiple myeloma (MM). Questions remain, however, about its efficacy compared with conventional chemo-therapy. [>Read full article in PDF]